Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Watkins

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Lancet (London, England)|December 19, 1987
"Intermediate" doses of tamoxifen in progressive advanced breast-cancerS M Watkins
Leukemia & Lymphoma|January 1, 1993
Predicting neutropenia after chemotherapy for lymphomaS M Watkins
Lancet (London, England)|May 22, 1971
Rival to the witch doctorS M Watkins
British Journal of Cancer|March 1, 1988
The value of high dose tamoxifen in postmenopausal breast cancer patients progressing on standard doses: a pilot studyS M Watkins
The British Journal of Surgery|June 1, 1976
Cancer prognosis predicted by preoperative lymphocyte responsiveness in vitroS M Watkins
Journal of the Royal College of Physicians of London|March 16, 2000
The legacy of Thomas Hodgkin (1798-1866)S M Watkins
The Journal of Obstetrics and Gynaecology of the British Commonwealth|November 1, 1972
Lymphocyte response to phytohaemagglutin in pregnancyS M Watkins
The Israel Medical Association Journal : IMAJ|November 4, 2000
Comprehensive lipid analysis: a powerful metanomic tool for predictive and diagnostic medicineS M Watkins
Lancet (London, England)|June 2, 1973
Cancer and impairment of cell-mediated immunityS M Watkins
Clinical and Experimental Immunology|May 1, 1973
The effects of surgery on lymphocyte transformation in patients with cancerS M Watkins
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Lancet (London, England)|December 19, 1987
"Intermediate" doses of tamoxifen in progressive advanced breast-cancerS M Watkins
Leukemia & Lymphoma|January 1, 1993
Predicting neutropenia after chemotherapy for lymphomaS M Watkins
Lancet (London, England)|May 22, 1971
Rival to the witch doctorS M Watkins
British Journal of Cancer|March 1, 1988
The value of high dose tamoxifen in postmenopausal breast cancer patients progressing on standard doses: a pilot studyS M Watkins
The British Journal of Surgery|June 1, 1976
Cancer prognosis predicted by preoperative lymphocyte responsiveness in vitroS M Watkins
Journal of the Royal College of Physicians of London|March 16, 2000
The legacy of Thomas Hodgkin (1798-1866)S M Watkins
The Journal of Obstetrics and Gynaecology of the British Commonwealth|November 1, 1972
Lymphocyte response to phytohaemagglutin in pregnancyS M Watkins
The Israel Medical Association Journal : IMAJ|November 4, 2000
Comprehensive lipid analysis: a powerful metanomic tool for predictive and diagnostic medicineS M Watkins
Lancet (London, England)|June 2, 1973
Cancer and impairment of cell-mediated immunityS M Watkins
Clinical and Experimental Immunology|May 1, 1973
The effects of surgery on lymphocyte transformation in patients with cancerS M Watkins
Pageof 5